Increased prevalence of risk factors for morbidity and mortality in the US hispanic CF population

Pediatric Pulmonology

Volumn 44, Issue 6, 2009, Pages 594-601

  Watts, Kimberly Danieli ^a,b,c   Seshadri, Roopa ^a,b   Sullivan, Christine ^a   McColley, Susanna A ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c 2300 Children's Plaza ^*  (United States)

Author keywords

Genotype; Risk factors; Socioeconomic factors; Vulnerable populations

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; FEMALE; HISPANIC; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SOCIAL STATUS;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HISPANIC AMERICANS; HUMANS; LIVER DISEASES; MALE; ODDS RATIO; PREVALENCE; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 67249097873     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21037     Document Type: Article

References (53)

1. O'Connor GT, Quinton HB, Kahn R, Robichaud P, Maddock J, Lever T, Detzer M, Brooks JG, Northern New England Cystic Fibrosis Consortium. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol 2002;33:99-105. (Pubitemid 34123684)
2. O'Connor GT, Marshall B, Quinton H, Yankaskas J, Stroud P, McColley SA, Goss C, Hughes B, Hazles L, Sabadosa K, Guill M, Campbell P. Public reporting of cystic fibrosis outcomes: methods for case-mix adjustment [abstract]. Pediatr Pulmonol Suppl 2006;29S:119-120.
3. Cystic Fibrosis Foundation Patient Registry. 2003 Annual Data Report to the Center Directors. Bethesda, Maryland: Cystic Fibrosis Foundation; 2004.
4. DeNavas-Walt C, Proctor BD, Smith JC. U.S. Census Bureau, Current Population Reports, P60-235, Income, Poverty, and Health Insurance Coverage in the United States: 2007, US Government Printing Office, Washington, DC, 2008.
5. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331-1337. (Pubitemid 32506595)
6. Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, Greally P, Hayes R, Bourke B. Cystic fibrosis-associated liver disease: a population-based study [see comment]. J Pediatr 2004;145:327-332. (Pubitemid 39165680)
7. McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest 2006;130:1441-1447. (Pubitemid 44786738)
8. Rodman DM, Polis JM, Heltshe SL, Sontag MK, Chacon C, Rodman RV, Brayshaw SJ, Huitt GA, Iseman MD, Saavedra MT, Taussig LM, Wagener JS, Accurso FJ, Nick JA. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 2005;171:621-626. (Pubitemid 40365418)
9. Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001;32:277-287. (Pubitemid 32938876)
10. Pedreira CC, Robert RGD, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ. Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 2005;39:276-280. (Pubitemid 40460698)
11. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl MEB, Wagener JS, Regelmann WE, Johnson CA, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis [see comment]. J Pediatr 2007;151:134-139.
12. Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert J-J. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008;152:540-545.
13. Minicucci L, Lorini R, Giannattasio A, Colombo C, Iapichino L, Reali MF, Padoan R, Calevo MG, Casciaro R, De Alessandri A, Haupt R. Liver disease as risk factor for cystic fibrosis-related diabetes development. Acta Paediatr 2007;96:736-739. (Pubitemid 46653185)
14. O'Connor GT, Quinton HB, Kneeland T, Kahn R, Lever T, Maddock J, Robichaud P, Detzer M, Swartz DR. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003;111:e333-e339.
15. Schechter MS. Non-genetic influences on CF lung disease: the role of sociodemographic characteristics, environmental exposures and healthcare interventions. Pediatr Pulmonol Suppl 2004;26:82-85. (Pubitemid 38222419)
16. FitzSimmons SC. The changing epidemiology of cystic fibrosis [see comment]. J Pediatr 1993;122:1-9. (Pubitemid 23010675)
17. Crapo RO, Jensen RL, Lockey JE, Aldrich V, Elliott CG. Normal spirometric values in healthy Hispanic Americans. Chest 1990;98:1435-1439.
18. Rosner B, Prineas R, Loggie J, Daniels SR. Percentiles for body mass index in U.S. children 5 to 17 years of age [see comment]. J Pediatr 1998;132:211-222. (Pubitemid 28125169)
19. Hankinson JLP, Crapo ROMDF, Jensen RLP. Spirometric reference values for the 6-s FVC maneuver*. Chest 2003;124:1805-1811. (Pubitemid 37433576)
20. Konstan MW, Butler SM, Wohl MEB, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003;142:624-630.
21. Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J Pediatr 2005;147:S11-S14. (Pubitemid 41400252)
22. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJ, Hodson ME, Anker SD, Henein MY. Wasting as an independent predictor of mortality in patients with cystic fibrosis [see comment]. Thorax 2001;56:746-750. (Pubitemid 32917542)
23. Wong LJ, Wang J, Zhang YH, Hsu E, Heim RA, Bowman CM, Woo MS. Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat 2001;18:296-307. (Pubitemid 32916860)
24. Alper OM, Wong L-JC, Young S, Pearl M, Graham S, Sherwin J, Nussbaum E, Nielson D, Platzker A, Davies Z, Lieberthal A, Chin T, Shay G, Hardy K, Kharrazi M. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients [erratum appears in Hum Mutat. 2005 Feb;25(2):223]. Hum Mutat 2004;24:353.
25. Schrijver I, Ramalingam S, Sankaran R, Swanson S, Dunlop CLM, Keiles S, Moss RB, Oehlert J, Gardner P, Wassman ER, Kammesheidt A. Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum. J Mol Diagn 2005;7:289-299. (Pubitemid 40668313)
26. Arzimanoglou II, Tuchman A, Li Z, Gilbert F, Denning C, Valverde K, Zar H, Quittell L, Arzimanoglou I. Cystic fibrosis carrier screening in Hispanics [see comment] [erratum appears in Am J Hum Genet 1996 Sep; 59(2):492]. Am J Hum Genet 1995;56:544-547.
27. Villarreal MT, Chavez M, Lezana JL, Cuevas F, Carnevale A, Codova E, del Angel RM, Orozco L. G542X mutation in Mexican cystic fibrosis patients. Clin Genet 1996;49:54-56. (Pubitemid 26090414)
28. Castellani C, Cuppens H, Macek M, Jr., Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, Casals T, Claustres M, Cutting GR, Dequeker E, Dodge J, Doull I, Farrell P, Ferec C, Girodon E, Johannesson M, Kerem B, Knowles M, Munck A, Pignatti PF, Radojkovic D, Rizzotti P, Schwarz M, Stuhrmann M, Tzetis M, Zielenski J, Elborn JS. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008;7:179-196.
29. Mickle JE, Cutting GR. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am 2000;84:597-607. (Pubitemid 30346155)
30. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990;116:714-719. (Pubitemid 20162819)
31. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100. (Pubitemid 34809519)
32. Pamukcu A, Bush A, Buchdahl R. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol 1995;19:10-15.
33. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704. (Pubitemid 32417671)
34. Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992;12:158-161.
35. Martin AC, Laing IA, Zhang G, Brennan S, Winfield K, Sly PD, Stick SM, Goldblatt J, LeSouef PN. CD14 C-159T and early infection with Pseudomonas aeruginosa in children with cystic fibrosis. Respir Res 2005;6:63. (Pubitemid 41410172)
36. Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y, Sang R, Pereira L, Sun L, Berthiaume Y, Tsui L-C, Pare PD, Durie P, Corey M, Zielenski J. Complex two-gene modulation of lung disease severity in children with cystic fibrosis [see comment]. J Clin Invest 2008;118:1040-1049.
37. Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, Bentur L, Springer C, Vila Y, Branski D, Kerem B, Kerem E. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics 1999;103:52-57. (Pubitemid 29281928)
38. Lamireau T, Monnereau S, Martin S, Marcotte J-E, Winnock M, Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study [see comment]. J Hepatol 2004;41:920-925. (Pubitemid 39575658)
39. Fiscella K, Franks P, Doescher MP, Saver BG. Disparities in health care by race, ethnicity, and language among the insured: findings from a national sample. Med Care 2002;40:52-59.
40. Satchell M, Pati S. Insurance gaps among vulnerable children in the United States, 1999-2001. Pediatrics 2005;116:1155-1161.
41. DiMatteo MR. Enhancing patient adherence to medical recommendations. J Am Med Assoc 1994;271:79. (Pubitemid 24020584)
42. Weinick RM, Jacobs EA, Stone LC, Ortega AN, Burstin H. Hispanic healthcare disparities: challenging the myth of a monolithic Hispanic population. Med Care 2004;42:313-320.
43. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR, Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis [see comment]. N Engl J Med 2005;353:1443-1453. (Pubitemid 41400918)
44. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis [see comment]. Thorax 2000;55:459-462.
45. Stanke F, Becker T, Cuppens H, Kumar V, Cassiman J-J, Jansen S, Radojkovic D, Siebert B, Yarden J, Ussery DW, Wienker TF, Tummler B. The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Hum Genet 2006;119:331-343.
46. Henrion-Caude A, Flamant C, Roussey M, Housset C, Flahault A, Fryer AA, Chadelat K, Strange RC, Clement A. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism [see comment]. Hepatology 2002;36:913-917.
47. Stonebraker JRFK, Ling SC, Cipolli M, Debray D, Fernandez A, Lacaille F, Repetto G, Rowland M, Taylor C, Wainwright C, Wilschanski M, Pace RG, Wood SD, Dorfman R, Wright FR, Drumm ML, Zielenski J, Lange EM, Durie PR, Knowles MR. Genetic modifiers of severe liver disease in cystic fibrosis: a replication study. Pediatr Pulmonol Suppl 2007;30:381.
48. Arias E, Anderson RN, Kung H-C, Murphy SL, Kochanek KD. Deaths: final data for 2001. Natl Vital Stat Rep 2003;52:1-115.
49. Mathews TJ, Menacker F, MacDorman MF. Infant mortality statistics from the 2001 period linked birth/infant death data set. Natl Vital Stat Rep 2003;52:1-28.
50. Morgenstern V, Zutavern A, Cyrys J, Brockow I, Koletzko S, Kramer U, Behrendt H, Herbarth O, von Berg A, Bauer CP, Wichmann HE, Heinrich J, Group GS, Group LS. Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med 2008;177: 1331-1337. (Pubitemid 351860910)
51. Gupta RS, Zhang X, Sharp LK, Shannon JJ, Weiss KB. Geographic variability in childhood asthma prevalence in Chicago. J Allergy Clin Immunol 2008;121:639-645. e1. Epub 2008 Feb 4.
52. Ma J, Kouznetsova M, Lessner L, Carpenter DO. Asthma and infectious respiratory disease in children-correlation to residence near hazardous waste sites. Paediatr Respir Rev 2007;8:292-298. (Pubitemid 350082035)
53. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med 2004;169:816-821. (Pubitemid 38402457)